Cargando…
Drug repurposing and cytokine management in response to COVID-19: A review
Coronavirus disease 2019 (COVID-19), the infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an aggressive disease that attacks the respiratory tract and has a higher fatality rate than seasonal influenza. The COVID‐19 pandemic is a global health crisis,...
Autores principales: | Heimfarth, Luana, Serafini, Mairim Russo, Martins-Filho, Paulo Ricardo, Quintans, Jullyana de Souza Siqueira, Quintans-Júnior, Lucindo José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457938/ https://www.ncbi.nlm.nih.gov/pubmed/32919216 http://dx.doi.org/10.1016/j.intimp.2020.106947 |
Ejemplares similares
-
Bradykinin-target therapies in SARS-CoV-2 infection: current evidence and perspectives
por: da Silva, Manuele Figueiredo, et al.
Publicado: (2022) -
Cyclodextrin–Drug Inclusion Complexes: In Vivo and In Vitro Approaches
por: Carneiro, Simone Braga, et al.
Publicado: (2019) -
Oxidative stress and inflammatory markers in patients with COVID-19: Potential role of RAGE, HMGB1, GFAP and COX-2 in disease severity
por: Rocha Santos Passos, Fabiolla, et al.
Publicado: (2022) -
Ivermectin: Panacea or true promise for COVID-19
por: Heimfarth, Luana, et al.
Publicado: (2020) -
Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2021)